Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.0591
-0.0199 (-25.19%)
Nov 6, 2026, 4:00 PM EST
Inhibitor Therapeutics Market Cap
Inhibitor Therapeutics has a market cap or net worth of $10.27 million as of November 9, 2026. It is the 39,355th most valuable company in the world and the 5,380th biggest in the United States. Its market cap has increased by 32.26% in one year.
Market Cap
10.27M
Enterprise Value
9.80M
Revenue
n/a
Global Rank
Country Rank
#5,380 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 29, 1997, Inhibitor Therapeutics's market cap has decreased from 14.08M to 10.27M, a decrease of -27.03%. That is a compound annual growth rate of -1.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 10.27M | 32.26% |
| Dec 31, 2025 | 7.77M | -25.02% |
| Dec 31, 2024 | 10.36M | -34.56% |
| Dec 28, 2023 | 15.83M | -57.47% |
| Dec 28, 2022 | 37.21M | -34.06% |
| Dec 30, 2021 | 56.43M | 332.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 22.27M |
| Biomind Labs | 19.41M |
| Vicapsys Life Sciences | 16.19M |
| Synlogic | 13.47M |
| Brainstorm Cell Therapeutics | 12.83M |
| Hepion Pharmaceuticals | 12.01M |
| Anebulo Pharmaceuticals | 11.22M |
| NDT Pharmaceuticals | 7.51M |